search
Back to results

Infiltrations With Collagen in Episiotomy and Cesarean Scars

Primary Purpose

Pelvic Pain

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Collagen
Rehabilitation sessions
Sponsored by
Althaia Xarxa Assistencial Universitària de Manresa
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pelvic Pain focused on measuring Episiotomy, Pain, Colagen

Eligibility Criteria

18 Years - 45 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  1. Patients between 18-45 years old.
  2. Between 2 and 36 months post-partum
  3. Accept participate in the study and sign the informed consent.

Exclusion Criteria:

  1. Mental or cognitive disorder that prevents comprehension.
  2. Being pregnant.
  3. Pacemaker carriers.
  4. On treatment with oral anticoagulants.
  5. Local infections at the point of infiltration.
  6. Total or partial denervation of the pelvic floor.
  7. Neurological diseases: AVC, LM, MS.

Sites / Locations

  • Althaia Xarxa Assistencial Universitària de Manresa

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Collagen group

Control group

Arm Description

Patients will receive 3 to 5 infiltrations of collagen on the scar once a week. Patients will receive the conventional treatment of 8 rehabilitation sessions with massage therapy techniques, muscle stretches and fascial work. The rehabilitation sessions will always be carried out by the same physiotherapist specialized in pelvic floor. Two rehabilitation sessions per week during four weeks. The rehabilitation sessions will last 45 minutes.

Patients will receive the conventional treatment of 8 rehabilitation sessions with massage therapy techniques, muscle stretches and fascial work. The rehabilitation sessions will always be carried out by the same physiotherapist specialized in pelvic floor. Two rehabilitation sessions per week during four weeks. The rehabilitation sessions will last 45 minutes.

Outcomes

Primary Outcome Measures

Pain caused by the scar (VAS)
Pain caused by the scar according to the Visual Analogue Scale (VAS). Range 0 to 10. Higher values represent worse pain.
Pain caused by the scar (MPQ)
Pain caused by the scar according to the Short Form McGill Pain (Questionnaire (MPQ). Range 0 to 78. Three dimensions: Sensory (12 ítems), Affective (3 ítems), Evaluative (1 ítem). Higher score higher level of pain.

Secondary Outcome Measures

Aspect of the scar (VSS)
Aspect of the scar according to the Vancouver Scar Scale (VSS). Range 0 to 10. 0 (representing normal skin) and 10 (representing worst scar imaginable).
Aspect of the scar (PSAS)
Aspect of the scar according to according to the patient component (PSAS) of the Scale of objective assessment Patient and Observer (Patient and Observer Scar Assesment Scale POSAS). The PSAS consist of six parameters: scar-related pain, itchness, color, stiffeness, thickness, and irregularity. Each parameter used a 10-point scoring system, with 1 representing normal skin and 10 representing the worst scar imaginable.
Subjective satisfaction of the clinician (PGI-I)
Subjective satisfaction of the clinician according to Patient Global Impression of Im,provement (PGI-I). Single question asking the patient to rate their satisfaction now, as compared with how it was prior to before beginning treatment on a scale from 1-Very much better to 7 -Very much worse.
Subjective satisfaction of the clinician (CGI-I)
Subjective satisfaction of the clinician according to Clinician Global Impression of Improvement (CGI-I). Single question asking the clinician to rate their satisfaction now, as compared with how it was prior to before beginning treatment on a scale from 1- Much better to 5-Much worse.

Full Information

First Posted
January 2, 2019
Last Updated
October 1, 2019
Sponsor
Althaia Xarxa Assistencial Universitària de Manresa
search

1. Study Identification

Unique Protocol Identification Number
NCT04112888
Brief Title
Infiltrations With Collagen in Episiotomy and Cesarean Scars
Official Title
Efficacy of Infiltrations With Collagen in Pelvic Pain Caused by Episiotomy and Cesarean Scars. Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
October 2019
Overall Recruitment Status
Completed
Study Start Date
May 1, 2017 (Actual)
Primary Completion Date
April 1, 2018 (Actual)
Study Completion Date
April 1, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Althaia Xarxa Assistencial Universitària de Manresa

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
One of the causes of pelvic pain is secondary to scarring due to episiotomy or cesarean after delivery.The pain of episiotomies or cesarean scars can be generalized at the level of the perineum, or more specifically at the level of the scar. For all these reasons, the presence of painful scars after a delivery, either by a cesarean or an episiotomy produces a perception of pelvic pain and change is your body schema and a series of negative connotations such as secondary dyspareunia, affective alterations, etc. To this, the investigators must add the important role that the psychological and social aspects can play in the development and perpetuation of a pain of these characteristics. The perception of pain is subjective and its intensity will be perceived based on many variables in each individual. The psycho-corporal representation of the episiotomy and/or cesarean section and its consequences will depend on each woman. In addition to the physical aspect, the scar of the episiotomy is the testimony of the birth and its complications. It causes a change in the representation of the body and the sex of the patient. The objective of this study is to evaluate the efficacy of collagen infiltrations in pelvic pain and the appearance of painful scars of episiotomies and/or cesareans compared to conventional treatment with rehabilitation.
Detailed Description
Randomized clinical trial to evaluate the efficacy of collagen infiltrations in pelvic pain caused by cesarean scars and/or episiotomies. Those patients who are referred to the Rehabilitation consultation for pelvic pain secondary to pain in the cesarean/episiotomy scar who meet the inclusion criteria and who agree to participate and sign the informed consent will be included. In the baseline assessment, the patient's clinical information will be collected: age, obstetric history, pathological history, active treatments and if they breastfeed. The following questionnaires will be passed: the Visual Analogue Scale (VAS) and the Short Form McGill Pain Questionnaire (SF-MPQ) to evaluate the pain caused by the scar, the Vancouver Scale of Healing (VSS) and the Patient Component (PSAS) of the Patient and Observer Objective Assessment Scale (POSAS) for the evaluation of the scar and initial photograph of the scar. A physical examination of the pelvic floor will be performed and the areas to be infiltrated will be detected. Patients will be randomly assigned to a Control group, will perform the conventional treatment, and an Experimental Group, who will perform the conventional treatment and will also have 3-5 infiltrations with collagen. At 6 and 16 weeks to finalize the treatment, a blinded assessor will perform the final assessment by passing the questionnaires used in the baseline assessment. The subjective satisfaction of the clinician and the patient will also be assessed using the questionnaires Clinical Global Improvement Impression Scale (GGI-I) and the Patient Global Improvement Impression Scale (PGI-I).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pelvic Pain
Keywords
Episiotomy, Pain, Colagen

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
16 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Collagen group
Arm Type
Experimental
Arm Description
Patients will receive 3 to 5 infiltrations of collagen on the scar once a week. Patients will receive the conventional treatment of 8 rehabilitation sessions with massage therapy techniques, muscle stretches and fascial work. The rehabilitation sessions will always be carried out by the same physiotherapist specialized in pelvic floor. Two rehabilitation sessions per week during four weeks. The rehabilitation sessions will last 45 minutes.
Arm Title
Control group
Arm Type
Active Comparator
Arm Description
Patients will receive the conventional treatment of 8 rehabilitation sessions with massage therapy techniques, muscle stretches and fascial work. The rehabilitation sessions will always be carried out by the same physiotherapist specialized in pelvic floor. Two rehabilitation sessions per week during four weeks. The rehabilitation sessions will last 45 minutes.
Intervention Type
Combination Product
Intervention Name(s)
Collagen
Intervention Description
Patients will receive 3 to 5 collagen infiltrations in the scar once per week. Patients with episiotomy will receive 3 collagen infiltrations while patients who underwent a cesarean section will receive 5 collagen infiltrations. The infiltration will be done by tunneling technique, that is, it will be applied along the scar, placing the needle almost tangential to the entire length of the area, then it will be injected and at the same time the needle will be removed. Infiltrations will be carried out intradermally, previously performing asepsis in the area to be infiltrated. 2 ml syringes will be used to infiltrate the episiotomy scars (we will use 1 vial of 2 ml ) and 5 ml for cesarean scars (2 vials of 2 ml ) and sterile needles of 30G, 13mm.
Intervention Type
Procedure
Intervention Name(s)
Rehabilitation sessions
Intervention Description
Patients will receive the conventional treatment of 8 rehabilitation sessions with massage therapy techniques, muscle stretches and fascial work. The rehabilitation sessions will always be carried out by the same physiotherapist specialized in pelvic floor. There will be two sessions per week for four weeks. The sessions will last 45 minutes.
Primary Outcome Measure Information:
Title
Pain caused by the scar (VAS)
Description
Pain caused by the scar according to the Visual Analogue Scale (VAS). Range 0 to 10. Higher values represent worse pain.
Time Frame
6 weeks after the end of treatment
Title
Pain caused by the scar (MPQ)
Description
Pain caused by the scar according to the Short Form McGill Pain (Questionnaire (MPQ). Range 0 to 78. Three dimensions: Sensory (12 ítems), Affective (3 ítems), Evaluative (1 ítem). Higher score higher level of pain.
Time Frame
6 weeks after the end of treatment
Secondary Outcome Measure Information:
Title
Aspect of the scar (VSS)
Description
Aspect of the scar according to the Vancouver Scar Scale (VSS). Range 0 to 10. 0 (representing normal skin) and 10 (representing worst scar imaginable).
Time Frame
6 weeks after the end of treatment
Title
Aspect of the scar (PSAS)
Description
Aspect of the scar according to according to the patient component (PSAS) of the Scale of objective assessment Patient and Observer (Patient and Observer Scar Assesment Scale POSAS). The PSAS consist of six parameters: scar-related pain, itchness, color, stiffeness, thickness, and irregularity. Each parameter used a 10-point scoring system, with 1 representing normal skin and 10 representing the worst scar imaginable.
Time Frame
6 weeks after the end of treatment
Title
Subjective satisfaction of the clinician (PGI-I)
Description
Subjective satisfaction of the clinician according to Patient Global Impression of Im,provement (PGI-I). Single question asking the patient to rate their satisfaction now, as compared with how it was prior to before beginning treatment on a scale from 1-Very much better to 7 -Very much worse.
Time Frame
6 weeks after the end of treatment
Title
Subjective satisfaction of the clinician (CGI-I)
Description
Subjective satisfaction of the clinician according to Clinician Global Impression of Improvement (CGI-I). Single question asking the clinician to rate their satisfaction now, as compared with how it was prior to before beginning treatment on a scale from 1- Much better to 5-Much worse.
Time Frame
6 weeks after the end of treatment

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Patients between 18-45 years old. Between 2 and 36 months post-partum Accept participate in the study and sign the informed consent. Exclusion Criteria: Mental or cognitive disorder that prevents comprehension. Being pregnant. Pacemaker carriers. On treatment with oral anticoagulants. Local infections at the point of infiltration. Total or partial denervation of the pelvic floor. Neurological diseases: AVC, LM, MS.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Georgia Romero-Culleres, MD, PhD
Organizational Affiliation
Althaia Xarxa Assistencial Universitària de Manresa
Official's Role
Principal Investigator
Facility Information:
Facility Name
Althaia Xarxa Assistencial Universitària de Manresa
City
Manresa
State/Province
Barcelona
ZIP/Postal Code
08243
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Infiltrations With Collagen in Episiotomy and Cesarean Scars

We'll reach out to this number within 24 hrs